- Home
- ACN vs BMY Comparison
ACN vs BMY Comparison
Compare ACN & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACN | BMY |
|---|---|---|
| Founded | 1989 | 1887 |
| Country | Ireland | United States |
| Employees | N/A | 32500 |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.2B | 123.7B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACN | BMY |
|---|---|---|
| Price | $192.70 | $58.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 16 |
| Target Price | ★ $270.81 | $61.81 |
| AVG Volume (30 Days) | 5.6M | ★ 9.6M |
| Earning Date | 03-19-2026 | 04-30-2026 |
| Dividend Yield | 3.32% | ★ 4.24% |
| EPS Growth | ★ 6.21 | N/A |
| EPS | ★ 6.47 | N/A |
| Revenue | ★ $69,672,977,000.00 | N/A |
| Revenue This Year | $7.15 | N/A |
| Revenue Next Year | $5.42 | N/A |
| P/E Ratio | $30.35 | ★ $17.26 |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $187.00 | $42.52 |
| 52 Week High | $322.86 | $62.89 |
Technical Indicators
Market Signals| Indicator | ACN | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 36.43 | 46.27 |
| Support Level | $187.86 | $53.88 |
| Resistance Level | $207.98 | $62.47 |
| Average True Range (ATR) | 7.56 | 1.18 |
| MACD | 0.96 | -0.20 |
| Stochastic Oscillator | 26.17 | 43.40 |
Price Performance
Historical ComparisonAbout ACN Accenture plc (Ireland)
Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount with around 800,000 employees in over 120 countries.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.